Should GLP-1 agonists be considered an alternative or adjunct to pediatric metabolic and bariatric surgery? more questions than answers

Surg Obes Relat Dis. 2024 Oct 26:S1550-7289(24)00861-X. doi: 10.1016/j.soard.2024.10.018. Online ahead of print.
No abstract available

Keywords: Bariatric; GLP-1; Obesity; Pediatric; Pharmacotherapy.